Chebigen Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 4

Chebigen General Information

Description

Manufacturer of a dual microcapsule technology intended to deliver raw substances into the human body effectively. The company produces lactobacillus items, healthy functional food and cosmetics with the application of technology and developed specialized enterprise for the purpose of living stronger more rewarding lives.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 62, Banryong-ro
  • Deokjin-gu
  • Jeonju-si, Jeonbuk Special Self-Governing
  • South Korea
+82
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 62, Banryong-ro
  • Deokjin-gu
  • Jeonju-si, Jeonbuk Special Self-Governing
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Chebigen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Chebigen‘s full profile, request access.

Request a free trial

Chebigen Patents

Chebigen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20100080851-A1 Method of preparing a microcapsule containing unsaturated fatty acids, the microcapsule prepared by the method, and articles containing the microcapsule Active 16-Aug-2006
US-8282961-B2 Method of preparing a microcapsule containing unsaturated fatty acids, the microcapsule prepared by the method, and articles containing the microcapsule Inactive 16-Aug-2006
WO-2008020680-A1 The method of preparing a microcapsule containing unsaturated fatty acids, the microcapsule prepared by the method, and articles containing the microcapsule Inactive 16-Aug-2006
AU-2003277737-A1 A noble geobacillus thermodenitrificans cbg-a1 strain expressing thermostable l-arabinose isomerase activity, the said enzyme and tagatose-production method Inactive 15-Nov-2003
AU-2003277737-A8 A noble geobacillus thermodenitrificans cbg-a1 strain expressing thermostable l-arabinose isomerase activity, the said enzyme and tagatose-production method Inactive 15-Nov-2003 C12N9/90
To view Chebigen’s complete patent history, request access »

Chebigen Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Chebigen‘s full profile, request access.

Request a free trial

Chebigen FAQs

  • When was Chebigen founded?

    Chebigen was founded in 2000.

  • Where is Chebigen headquartered?

    Chebigen is headquartered in Jeonju-si, South Korea.

  • What industry is Chebigen in?

    Chebigen’s primary industry is Drug Delivery.

  • Is Chebigen a private or public company?

    Chebigen is a Private company.

  • What is Chebigen’s current revenue?

    The current revenue for Chebigen is .

  • How much funding has Chebigen raised over time?

    Chebigen has raised $778K.

  • Who are Chebigen’s investors?

    Woori Venture Partners and Seoul Investment Partners have invested in Chebigen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process